Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) Tax Provisions: 2021-2024

Historic Tax Provisions for Arcus Biosciences (RCUS) over the last 1 years, with Dec 2024 value amounting to $1.0 million.

  • Arcus Biosciences' Tax Provisions changed negligibly% to $1.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 16.67%. This contributed to the annual value of $1.0 million for FY2024, which is 83.33% down from last year.
  • According to the latest figures from Q4 2024, Arcus Biosciences' Tax Provisions is $1.0 million, which was down 0.00% from $1.0 million recorded in Q4 2023.
  • In the past 5 years, Arcus Biosciences' Tax Provisions ranged from a high of $2.0 million in Q4 2021 and a low of $1.0 million during Q1 2022.
  • Its 3-year average for Tax Provisions is $1.3 million, with a median of $1.0 million in 2024.
  • Data for Arcus Biosciences' Tax Provisions shows a peak YoY spiked of 100.00% (in 2023) over the last 5 years.
  • Over the past 4 years, Arcus Biosciences' Tax Provisions (Quarterly) stood at $2.0 million in 2021, then reached $1.0 million in 2022, then soared by 100.00% to $1.0 million in 2023, then remained steady at $1.0 million in 2024.
  • Its Tax Provisions was $1.0 million in Q4 2024, compared to $1.0 million in Q4 2023 and $2.0 million in Q3 2023.